Moderna, Inc. (LON:0A45)
London · Delayed Price · Currency is GBP · Price in USD 40.31
-2.91 (-6.73%)
At close: Feb 11, 2026
Moderna Market Cap
Moderna has a market cap or net worth of 11.6 billion as of February 12, 2026. Its market cap has decreased by -16.58% in one year.
Market Cap
11.60B
Enterprise Value
7.27B
Revenue
1.66B
Ranking
n/a
PE Ratio
n/a
Stock Price
40.31
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from 4.80B to 11.60B, an increase of 141.64%. That is a compound annual growth rate of 13.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 11.60B | 35.50% |
| Dec 31, 2025 | 8.56B | -33.01% |
| Dec 31, 2024 | 12.78B | -57.07% |
| Dec 29, 2023 | 29.77B | -48.02% |
| Dec 30, 2022 | 57.27B | -24.69% |
| Dec 31, 2021 | 76.05B | 151.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NEXT plc | 14.99B |
| Legal & General Group | 14.81B |
| Associated British Foods | 13.54B |
| Halma | 13.40B |
| Zegona Communications | 12.06B |
| Airtel Africa | 11.95B |
| Rentokil Initial | 11.57B |
| Smith & Nephew | 10.82B |